Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy
Frontiers in Bioengineering and Biotechnology · 23.07.2025 · 13
DOI: 10.3389/fbioe.2025.1601673 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 23.07.2025. Verfasst von Kehan Wang. Beteiligte Einrichtung: Hubei University of Chinese Medicine, Wuhan, Hubei, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is an exceedingly aggressive primary brain neoplasm characterized by a dismal prognosis owing to its invasiveness, heterogeneity, and immunity to conventional therapies. Conventional therapies, including surgery, chemotherapy, and radiotherapy, encounter constraints due to tumor evasion and physiological obstacles, such as the blood-tumor (BTB) and blood-brain barriers (BBB), which impact the treatment of GBM. Nanotechnology is employed to augment the permeability of anticancer agents through these barriers, thereby improving treatment efficacy and minimizing toxicity. Lipid-based nanoparticles, such as nanostructured lipid carriers (NLCs) and solid lipid nanoparticles (SLNs), offer drug encapsulation, stability, and controlled release, whereas metal nanoparticles, including gold and silver, augment imaging and photothermal therapy efficacy. This review investigates the traversal of nano carriers across the BBB and BTB, emphasizing the significance of dimensions, charge, and surface functionality, while underscoring the potential of nanotechnology in managing GBM. Advancements in nanomedicine possess the capacity to create more efficacious therapeutic strategies, markedly improving patient outcomes in the management of GBM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hubei University of Chinese Medicine, Wuhan, Hubei, China.
Zitieren
APA
Wang, K. (2025). Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy. Frontiers in Bioengineering and Biotechnology, 13. https://doi.org/10.3389/fbioe.2025.1601673
Vancouver
Wang K. Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy. Frontiers in Bioengineering and Biotechnology. 2025;13. doi:10.3389/fbioe.2025.1601673
BibTeX
@article{Wang2025,
author = {Wang, Kehan},
title = {Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2025},
volume = {13},
doi = {10.3389/fbioe.2025.1601673}
}
EUVIMED